Blab AI
Titan Announces 1 Million AI Reinvestment and New Business-Platform Features at TitanUp 26
On June 7, 2026, Birmingham’s TitanUp 26 conference became the stage for a bold pivot: Titan, the UK’s leading pharmacy‑management system, announced a £1 million reinvestment in artificial‑intelligence (AI). The event, organized by Invatech Health Ltd—the parent of Titan PMR and Titanverse—drawn more than 1,500 independent pharmacy customers, also unveiled a re‑positioned business platform and a clinical‑AI roadmap.
The conference set out to show how independent pharmacies can build sustainable operating models. Delegates ranged from pharmacy owners and clinical speakers to technology partners and exhibitors. Highlights included live demonstrations, customer interviews, and a humanoid robot that conducted spontaneous interviews with attendees, sparking laughter and discussion.
Titan’s chief executive, Tariq Muhammad, framed the shift: “We will no longer be a PMR provider competing on features but an operating infrastructure for the next decade of independent community pharmacy.” He added that the £1 million will fund “own models, own infrastructure and the clinical governance behind it,” underscoring the need for AI that is built, not merely adopted.
Chief technology officer Wahid Muhammad echoed that sentiment, describing Titan’s approach as “build AI, not use AI.” He introduced Level Five Titan AI, a clinical‑checking automation designed to handle up to 90 % of clinical checks. The system is trained on hundreds of thousands of rows of dispensing data and is supported by a team of AI specialists, a PhD‑qualified engineering group, and an internal clinical team of pharmacists.
Beyond AI, Titan rolled out a suite of new features for Titanverse, its integrated business‑and‑finance platform. The update adds a concession‑management system, an integrated claims process that flags missing endorsements before submission, and a live view of expiring stock. A new stock‑management module offers cross‑branch transfer visibility, while a redesigned dispensary board and a one‑click MDS process for tray management streamline workflow.
Finance capabilities have expanded to deliver live gross‑profit visibility. Developed in partnership with the NHS Business Services Authority, the feature reverse‑engineers the FP34 pricing engine. Titanverse also now offers a mobile version for iOS and Android, featuring customizable KPI dashboards, prescription clinical checking, live finance summaries, integrated team messaging, and a consultation extension for private services.
Other speakers addressed broader industry themes. Michael Holden, managing director of MH Associates, warned that planning must keep pace with profit. Rahul Puri, a customer case study, stressed that “activity and profit are not the same thing,” urging pharmacies to focus on patient intent. Rhys Lloyd, co‑founder of PharmAppy, highlighted a consumer‑driven market where patients compare pharmacy experiences to Amazon and Uber. Ghulam Haydar of Allied Health Training underscored governance for private services, insisting that “if it’s not recorded, it didn’t happen” and urging owners to maintain audit trails and regulatory compliance.
Titan’s repositioning aligns with a wider trend of pharmacies diversifying revenue streams and boosting operational efficiency. The new AI and finance tools aim to reduce manual workload, enhance data visibility, and enable pharmacies to scale private clinical services.
The event concluded with user testimonials. Pritpal Grewal, owner of Balance Pharmacy, said the robot’s interviews saved him hours, while Malesh from Hayden Pharmacy noted that the new system freed him from dispensary work to focus on patient consultations.
Titan’s commitment to AI and platform expansion signals its intent to remain a key technology partner for community pharmacies. Future steps will likely include further AI model refinement, broader rollout of Titanverse features, and continued engagement with NHS partners.
The conference set out to show how independent pharmacies can build sustainable operating models. Delegates ranged from pharmacy owners and clinical speakers to technology partners and exhibitors. Highlights included live demonstrations, customer interviews, and a humanoid robot that conducted spontaneous interviews with attendees, sparking laughter and discussion.
Titan’s chief executive, Tariq Muhammad, framed the shift: “We will no longer be a PMR provider competing on features but an operating infrastructure for the next decade of independent community pharmacy.” He added that the £1 million will fund “own models, own infrastructure and the clinical governance behind it,” underscoring the need for AI that is built, not merely adopted.
Chief technology officer Wahid Muhammad echoed that sentiment, describing Titan’s approach as “build AI, not use AI.” He introduced Level Five Titan AI, a clinical‑checking automation designed to handle up to 90 % of clinical checks. The system is trained on hundreds of thousands of rows of dispensing data and is supported by a team of AI specialists, a PhD‑qualified engineering group, and an internal clinical team of pharmacists.
Beyond AI, Titan rolled out a suite of new features for Titanverse, its integrated business‑and‑finance platform. The update adds a concession‑management system, an integrated claims process that flags missing endorsements before submission, and a live view of expiring stock. A new stock‑management module offers cross‑branch transfer visibility, while a redesigned dispensary board and a one‑click MDS process for tray management streamline workflow.
Finance capabilities have expanded to deliver live gross‑profit visibility. Developed in partnership with the NHS Business Services Authority, the feature reverse‑engineers the FP34 pricing engine. Titanverse also now offers a mobile version for iOS and Android, featuring customizable KPI dashboards, prescription clinical checking, live finance summaries, integrated team messaging, and a consultation extension for private services.
Other speakers addressed broader industry themes. Michael Holden, managing director of MH Associates, warned that planning must keep pace with profit. Rahul Puri, a customer case study, stressed that “activity and profit are not the same thing,” urging pharmacies to focus on patient intent. Rhys Lloyd, co‑founder of PharmAppy, highlighted a consumer‑driven market where patients compare pharmacy experiences to Amazon and Uber. Ghulam Haydar of Allied Health Training underscored governance for private services, insisting that “if it’s not recorded, it didn’t happen” and urging owners to maintain audit trails and regulatory compliance.
Titan’s repositioning aligns with a wider trend of pharmacies diversifying revenue streams and boosting operational efficiency. The new AI and finance tools aim to reduce manual workload, enhance data visibility, and enable pharmacies to scale private clinical services.
The event concluded with user testimonials. Pritpal Grewal, owner of Balance Pharmacy, said the robot’s interviews saved him hours, while Malesh from Hayden Pharmacy noted that the new system freed him from dispensary work to focus on patient consultations.
Titan’s commitment to AI and platform expansion signals its intent to remain a key technology partner for community pharmacies. Future steps will likely include further AI model refinement, broader rollout of Titanverse features, and continued engagement with NHS partners.
